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ABSTRACT 
 
The World Health Organisation recognises adolescents as a key population vulnerable 
from acquiring HIV/AIDS, and adolescence is a critical stage of child growth and 
development. The adolescence period is often shaped by swift physical and cognitive 
changes as well as involving risk behaviour that impacts the adolescents’ health. The HIV 
prevalence data on South Africa shows that the percentage of HIV-infected children 
significantly increases between childhood to adolescence. South Africa has the largest 
antiretroviral therapy programme in the world; there is progress on initiating HIV-infected 
children onto treatment and they are surviving into adolescence. However, although there 
are existing local and World Health Organisation HIV status disclosure guidelines on 
children, informing the young adolescents’ HIV status (disclosure) during the childhood-
to-adolescence transition remains a challenge. Caregivers and healthcare workers often 
find HIV status disclosure on the children compromising, especially on young adolescents 
enrolled on ART.  
 
This study aims to determine the prevalence of HIV status disclosure, among a cohort of 
young adolescents enrolled on antiretroviral therapy at the thirteen public healthcare 
facilities, in the City of Johannesburg Region A sub-district. The retrospective study 
design was used to analyse the antiretroviral therapy monitoring data on the cohort of 
281 HIV-infected young adolescents aged between 10 to 14 years. The number of young 
adolescents on antiretroviral therapy in Region A and per healthcare facility was drawn 
from the Johannesburg District Health Information System; HIV status disclosure was 
extracted from the patient files kept at the healthcare facilities; and the antiretroviral 
therapy records, clinic adherence history and demographic characteristics were 
accessed on the Tier.net system. Using the IBM Statistical Package for Social Sciences 
software Version 25, data was analysed using frequency tables, summary statistics, and 
Pearson`s Chi-square tests. 
 
Like other studies on low, middle and high-income countries, this study found that out of 
a sample of 281 young adolescents enrolled on antiretroviral therapy, a relatively low 
percentage (26.3%) are fully disclosed of their HIV status, while a significant majority 
(73.7%) are only partially disclosed. South Africa is ranked as an upper-middle income 
country. This study further found that there is a very weak correlation between the HIV 
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status disclosure and viral load count which is the main antiretroviral therapy outcome. 
However, there is a relationship found between clinic adherence and HIV status 
disclosure; disclosure is found being strongly affected by clinic adherence. This study 
found that the prevalence of HIV status disclosure is high (70.3%) among the young 
adolescents adhering to clinic appointments, and low (29.7%) among those not adhering 
to clinic appointments. 
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Definition of terms 
 
Children: human population between the stage of birth and 18 years of age (Republic of 
South Africa, 2005). 
 
Adolescence: A stage of child growth from the age of 10 up to 19 years (WHO, 2011). 
Youth adolescents: children between the ages of 10 to 14 years (National Department of 
Health, 2016b; WHO. 2011). 
 
Caregiver: the parent, legal guardian or a person responsible for providing primary care 
to a child (Republic of South Africa, 2005). 
 
Child or adolescent HIV status disclosure: it is when an HIV-infected child gains 
knowledge of his or her HIV status (National Department of Health, 2016b). 
 
Partial HIV status disclosure: explaining to the HIV-infected child about germs, what 
germs can do to the immune system, the role of solider cells and how medicine helps the 
solider cells to fight the germ. At this stage the word HIV is avoided and not mentioned 
to the child (Right to Care, 2018). 
 
Full HIV status disclosure: the stage when the HIV virus is mentioned and explained to 
the infected child so that he/she acquires full knowledge of his/her HIV status (Right to 
Care, 2018). 
 
Post-disclosure: the ongoing sessions on a fully disclosed child in order to give more 
information about HIV treatment, care and support (Right to Care, 2018). 
 
HIV status disclosure prevalence: the existing number of HIV-infected children, in a place 
and at a given time, who know their status. 
 
Health: According to the WHO definition, health is a state of complete physical, mental 
and social well-being and not merely the absence of disease or infirmity (National 
Department of Health, 2016b). 
 
xiii 
 
Healthcare workers: any trained personnel such as Nurses, Doctors, Counsellors, Social 
Workers, or Psychologists providing health-related psychosocial support services to 
patients within or outside a healthcare facility (National Department of Health, 2016b). 
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CHAPTER ONE 
 
 INTRODUCTION 
 
1.1 Introduction 
This chapter introduces the study background, the concept of adolescence and status 
disclosure in the context of HIV infection among adolescents in South Africa. The chapter 
also outlines the research problem, research aim and objectives, the significance of the 
study, geographical demarcation and provides a description of the study area.  
 
1.2 Background 
Adolescence is a critical stage of child growth and development, and it is often shaped 
by swift physical and cognitive changes. The adolescence stage involves risk behaviour 
that has an impact on the health choices of adolescents. HIV infection among 
adolescents adversely affects their life, health choices and well-being; and the 
consequences are carried over into adulthood (Dick & Ferguson, 2015). The World 
Health Organisation (WHO) recognises that adolescents are one of the key populations 
among vulnerable people who are at risk of acquiring and spreading HIV/AIDS (WHO, 
2010).  
 
On a global scale and within the sub-Saharan African region, South Africa is one of the 
countries whose population is largely infected and affected by the HIV pandemic. Before 
the success of the Prevention of Mother-to-Child Transmission (PMTCT) programme, a 
large proportion of children in South Africa were born HIV-positive (National Department 
of Health, 2016a; United Nations Children’s’ Funds [UNICEF], 2017). However, there has 
been global progress (as well as in South Africa) on initiating HIV-infected children onto 
antiretroviral therapy (ART) and as a result, these children are surviving into adolescence.  
 
The HIV status disclosure process involves giving age-appropriate disease and treatment 
information incrementally to the adolescent enrolled on ART, and is aimed at improving 
treatment adherence (WHO, 2011; Sirikum et al., 2014; Cluver et al., 2015; National 
Department of Health, 2016a). During the childhood-to-adolescence transition, HIV 
status disclosure to young adolescents enrolled on ART remains a challenge for both 
caregivers and healthcare workers (National Department of Health, 2016b). In most 
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cases, concerns about the age of the HIV-infected child determine how long caregivers 
and healthcare workers can prolong informing the child of his/her HIV status.  
 
In both lower and high-income countries, the lack of HIV status disclosure among children 
enrolled on ART has been widely regarded as a barrier to treatment adherence (WHO, 
2011; Brown et al., 2011; Haberer et al., 2011; Vreeman et al., 2014). The World Bank 
(2017) ranks South Africa as one of the upper-middle income countries in Africa. Whilst 
HIV/AIDS mortality in South Africa decreased in other age groups between 2005 and 
2013, the mortality in the adolescent population doubled to 120 000 in 2013 (Dick & 
Ferguson, 2015). 
 
Given the importance of HIV treatment adherence and HIV status disclosure, a 
retrospective study was undertaken to determine the prevalence of HIV status disclosure 
on a cohort of young adolescents aged between 10 to 14 years and enrolled on ART at 
certain public health facilities in the Johannesburg area.  
 
1.3 Research problem 
South Africa is making considerable progress in providing effective ART programmes to 
children, and a significant number of HIV-infected children are entering into adolescence 
(Cluver et al., 2015). As HIV-infected children transit into early adolescence while being 
on the ART programme, some become defaulters or loss-to-follow patients, and some 
become ill or die because of disease progression. Also, informing young adolescents of 
their HIV status (disclosure) is important to achieve optimum treatment outcomes 
(Kasedde et al., 2014).  
 
Madiba (2012) found that in South Africa, relatively few HIV-infected children below the 
age of 14 years knew their status, despite being enrolled on ART. Despite having the 
WHO and South African HIV status disclosure guidelines for children, there are limited 
studies on the prevalence of status disclosure among young adolescents enrolled on ART 
and limited analyses on the impact of HIV status disclosure on ART outcomes in South 
Africa. 
 
In 2016, an estimated 55 000 adolescents died because of HIV/AIDS-related 
complications, and 90% of them lived in sub-Saharan Africa (UNICEF, 2017). HIV status 
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disclosure has been shown to improve treatment adherence and empower HIV-infected 
young adolescents to prevent further transmission (Cluver et al., 2015; Brown et al., 2011; 
Haberer et al., 2011).  
 
1.4  Aim and objectives 
The aim and objectives of this study are as follows: 
 
1.4.1 Aim 
The aim of this study is to conduct a situational analysis on the prevalence of HIV status 
disclosure, among a cohort of young adolescents aged between 10 to 14 years and 
enrolled on ART at public healthcare clinics in the City of Johannesburg, Region A sub-
district. 
 
1.4.2 Specific objectives 
The objectives of the study are to: 
- Determine the prevalence of HIV status disclosure among a representative 
population of young adolescents who are enrolled on ART. 
- Evaluate the correlation between HIV status disclosure and ART outcomes on 
infected young adolescents. 
 
1.5 The significance of the study 
Kranzer et al. (2017) indicates that studies on age-related cognitive and psychosocial 
development call for an analytical approach using narrow age-bands. This study is 
focused on the cohort of HIV-infected young adolescents aged between 10 to 14 years 
and who are enrolled on ART. Various cohort and programmatic studies often group HIV-
infected young adolescents with children in the age range of 0 –15 years. 
 
The South African National AIDS Council (SANAC) points out that research studies are 
important to build evidence-based knowledge during the implementation of the South 
African National Strategic Plan for HIV, STIs and TB 2017-2022 (SANAC, 2016). The 
evidence-based knowledge obtained from this study should strengthen HIV care and ART 
adherence among young adolescents, in line with the implemented WHO Disclosure 
Guidelines on HIV Disclosure Counselling for Children up to 12 Years of Age and South 
African National Disclosure Guidelines for Children and Adolescents in the context of 
4 
 
HIV, TB and Non-Communicable Diseases. The key outcomes of the study are to 
determine the prevalence of HIV status disclosure and to evaluate the correlation 
between status disclosure and ART outcomes among young adolescents enrolled on 
ART. 
 
1.6  Geographical demarcation and description of the study area 
 
Figure1.1. The City of Johannesburg (Region A) healthcare facilities mapping 
 
Map data ©2018 AfriGIS (Pty) Ltd, Google 
 
The study was focused on public healthcare facilities in the City of Johannesburg, Region 
A. The City of Johannesburg Metropolitan Municipality is sub-divided into seven 
administrative regions (sub-districts) to expedite services (City of Johannesburg, 2018). 
The study used ART monitoring data from the thirteen public healthcare clinics in the City 
of Johannesburg, Region A. The public healthcare clinics in Region A are Mpumelelo, 
Hikhensile, Thutukani, Ebony, Bophelong, Rabie Ridge, Mayibuye, Nizamiya, Halfway 
House, Midrand West, OR Tambo, Diepsloot South and Eyethu (City of Johannesburg, 
2018). The adolescents’ HIV programs and services provided at these public healthcare 
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facilities were supported by Right to Care and Zoe-Life, which are both donor-funded 
non-profit organisations. These two organisations support the Department of Health in 
the implementation of the South African National Disclosure Guidelines for Children and 
Adolescents in the context of HIV, TB and Non-Communicable Diseases, by providing 
training, technical support and mentoring to healthcare workers (National Department of 
Health, 2016b; Right to Care, 2018). 
 
SANAC (2016) indicates that the City of Johannesburg is one of the districts in South 
Africa (and in the Gauteng Province) with a high HIV burden. Considering that the district 
has many informal settlements, inhabited mostly by a mobile and migrant population, 
there is high HIV risk exposure and high HIV prevalence (SANAC, 2016; National 
Department of Health, 2016a). The City of Johannesburg, Region A has large informal 
settlements in Diepsloot, Cosmo City, Ebony, as well as Ivory Park next to Tembisa (City 
of Johannesburg, 2018).  
 
1.7 Structure of the dissertation 
This section outlines the sequence of chapters and the topics to be discussed in each 
Chapter of this dissertation. 
 
Figure 1.2. Dissertation structure 
 
 
 
 
    
 
     
 
                    
        
                               
 
                                          
 
 
   
 
 
 
Chapter 2: Literature Review 
Chapter 3: Research Methodology 
Chapter 4: Data Analysis, Results and Discussion 
Chapter 5: Conclusions and Recommendations 
 
 
 
Chapter 1: Introduction 
6 
 
1.8 Conclusion and summary 
This chapter has provided an introduction to the study in terms of the following: 
background information on the concept of adolescence and HIV, the research problem, 
research aim and objectives, the significance of the study, the geographic focus of the 
study and the overall structure of the dissertation. In Chapter Two, a wide variety of 
literature is reviewed from different studies covering key aspects related to HIV 
prevalence, HIV status disclosure and ART on adolescents. Chapter Three outlines the 
study methodology adopted, ethical considerations and the limitations of this study. The 
results of the data analysis and a detailed discussion of the results are provided in 
Chapter Four. Chapter Five discusses the conclusion reached by this study and 
recommendations for future studies. 
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CHAPTER TWO 
 LITERATURE REVIEW 
 
2.1 Introduction 
The preceding chapter gave an introductory overview of the study, its structure and 
stipulated the aim and objectives thereof. This chapter presents the literature from previous 
studies in various countries that has been reviewed to explore the subject of people living 
with HIV, adolescence, the prevalence of HIV status disclosure among young adolescents 
enrolled on ART, and the existing HIV status disclosure guidelines for children. Furthermore, 
literature on the factors associated with HIV status disclosure and the effects of disclosure 
on ART outcomes are also explored. 
 
2.2 Global overview of HIV infection and ART-related trends 
The WHO noted that more than 6 300 new HIV infections occurred each day worldwide 
in 2012, and an estimated 2 500 of these cases includes adolescents and young people 
between the ages of 15 and 24. According to the Joint United Nations Programme on 
HIV/AIDS (UNAIDS), in 2015 there was an increase of approximately 8 600 new HIV 
infections per week among adolescent girls and young women aged between 15 and 24 
years (UNAIDS, 2016). In the South African context, HIV transmission among adolescent 
girls and young women is in large measure driving the country’s HIV epidemic - about 2 
000 adolescent girls and young women between the ages of 15 and 24 are infected with 
HIV every week, accounting for roughly 100 000 of the 270 000 new national infections 
every year (SANAC, 2016).  
 
Nevertheless, in July 2016 the UNAIDS expressed that the reduction of new HIV 
infections globally had stalled. The estimated number of HIV-infected children below 15 
years of age and enrolled on ART globally almost doubled from 452 000 in the year 2010 
to 872 500 by the end of 2015 (WHO, 2016). Furthermore, the UNICEF also indicates 
that in 2016 alone, an estimated 55 000 adolescents died due to HIV/AIDS-related 
complications, with 90% of them living in sub-Saharan Africa (UNICEF, 2017). 
 
2.3 Overview of HIV infection and ART-related trends in South Africa 
  
South Africa has the largest ART programme in the world, and the HIV prevalence data 
shows that the percentage of HIV-infected children significantly increases between 
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childhood and adolescence (WHO, 2016; SANAC, 2016; National Department of Health, 
2016a). Out of the globally estimated 872 500 children below the age of 15 years who 
are enrolled on ART, more than 20% of them live in South Africa - thus the country has 
an estimated 320 000 children living with HIV (WHO, 2016). Gender tends to be relatively 
balanced in the cohorts of HIV-infected children due to perinatal infection, while girls 
account for a slightly greater proportion of infections in adolescent cohorts due to sexual 
risks (National Department of Health, 2016a; Kranzer et al., 2017). The success of the 
ART programme for HIV-infected children allows them to transit into adolescence and 
live longer (Pinzón-iregui et al., 2013; Sirikum et al., 2014; Atwiine et al., 2015). 
 
Despite notable reductions in HIV infection and HIV-related mortality rates in South 
Africa, an estimated 270 000 people became newly infected with HIV in 2016 and the 
number of deaths due to HIV are still staggering (SANAC, 2016). According to the 
UNAIDS (2017), HIV-related deaths among adolescents in South Africa during the period 
between 2005 and 2012 increased by 50%. Various research studies noted that the 
increase on HIV-related mortality among adolescents in South Africa and globally was 
primarily due to poor prioritization of the adolescent population in national HIV plans, 
inadequate provision of accessible HIV services and lack of support for infected 
adolescents to remain in HIV care and adhere to ART (WHO, 2013).  
 
With an estimated 7 million people (including children) living with HIV, South Africa has 
a maturing HIV epidemic (SANAC, 2016).  Furthermore, only an estimated 3,7 million 
people have been enrolled on ART in South Africa, implying that only 53% of the people 
eligible for HIV treatment have been reached in the country (WHO, 2016; SANAC, 2016). 
 
2.4 Adolescence and HIV status disclosure 
 
The WHO (2011) indicates that the adolescence stage is from 10 to 19 years of age, while 
young adolescents are defined as children between the ages of 10 to 14 years. The National 
Department of Health (2016b) also indicates that the young adolescents age between 10 to 
14 years is also known as the early adolescence stage. Adolescents are found across the 
key populations who are at higher risk of acquiring and contributing to the spread of 
HIV/AIDS. The key populations include sex workers, people injecting drugs, transgender 
people and homosexual individuals (WHO, 2010; WHO, 2013).  
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Unlike adults who have stable behaviour and more mature cognitive functioning, generally 
young adolescents face swift physical and psychological changes that affect their health-
related behaviour (Sawyer et al., 2012). Young adolescents in South Africa often find it 
difficult to constantly adhere to long-term medication such as ART, especially when their 
health status has not been fully disclosed to them (Jaspan et al., 2009; Hanghøj & Boisen, 
2014). Poor ART adherence among HIV-infected young adolescents is experienced in both 
low and high-income countries (Kranzer et al., 2017). 
  
HIV status disclosure for children enrolled on ART is all about informing them at an 
appropriate age that they are HIV positive (Vreeman et al., 2014).  According to the World 
Health Organization Disclosure Guidelines on HIV Disclosure Counselling for Children 
up to 12 Years of Age, children on ART must be informed of their HIV status during the 
period between the ages of 6 and 12 years (WHO, 2011). Furthermore, the HIV status 
disclosure process involves giving age-appropriate disease and treatment information 
incrementally to the child and aimed at improving treatment adherence (WHO, 2011; 
Sirikum et al., 2014; Cluver et al., 2015; National Department of Health, 2016a). Health 
status disclosure is a necessary and important step in long-term chronic disease 
management. HIV status disclosure, ART adherence and secondary HIV transmission are 
the common challenges that emerge globally when HIV-infected children transit into 
adolescent care. 
 
Vreeman et al. (2014) noted that because of increasing or developing maturity and 
independent treatment responsibility, HIV-infected young adolescents generally tends to 
know their HIV status more frequently than other children below 10 years of age. The onset 
of adolescence tends to gradually reduce the extent of a caregiver’s involvement in the 
adolescent’s healthcare and ART adherence (Sawyer et al., 2012). A healthcare worker 
providing ART adherence counselling to an undisclosed HIV-infected adolescent must be 
very cautious and avoid accidental status disclosure (National Department of Health, 
2016b). Hence, the National HIV Testing Services Policy in South Africa recommends that 
HIV status disclosure on infected children must happen before the onset of adolescence 
(National Department of Health, 2016a).  
 
Because most HIV infections among young children in South Africa are perinatal, caregivers 
and healthcare workers often find status disclosure compromising, as it sometimes involves 
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disclosing the parent’s HIV status to the children (Wiener et al., 2007; Pinzón-iregui et al., 
2013; National Department of Health, 2016b). 
 
2.5 HIV status disclosure guidelines for children on ART 
 
The WHO has been involved as a leading stakeholder in developing various global 
guidelines, policies and strategies to manage and control the HIV epidemic. The World 
Health Organization Disclosure Guidelines on HIV Disclosure Counselling for Children 
up to 12 Years of Age recommends informing children enrolled on ART their HIV status 
between the ages of 6 and 12 years (WHO, 2011). However, there are limited publications 
on standardised children or adolescents’ HIV status disclosure protocols in resource-
limited countries. Because there are differences in the level of HIV epidemic and 
variances of associated or determinant factors in different countries and settings, the 
UNAIDS recommends that countries make decisions based on country data, priorities 
and local contexts (UNAIDS, 2016). The UNAIDS also calls for a dramatic acceleration 
of country-level action. 
 
In line with the World Health Organization Guidelines on HIV Disclosure Counselling for 
Children up to 12 Years of Age, the South African National Department of Health 
developed and published in 2016 the National Disclosure Guidelines for Children and 
Adolescents in the context of HIV, TB and Non-Communicable Diseases (National 
Department of Health, 2016b). The nationally implemented guidelines are designed to 
guide caregivers and healthcare workers to conduct age-appropriate and health-
promoting HIV status disclosures among children enrolled on ART. The guidelines are 
also aimed at improving the long-term benefits of ART adherence (National Department 
of Health, 2016b). The Department of Health provides disclosure training and mentoring 
to healthcare workers in conjunction with supporting organisations and other partners. 
 
The South African National Disclosure Guidelines for Children and Adolescents in the 
context of HIV, TB and Non-Communicable Diseases are related to the National HIV 
Testing Services Policy. The National HIV Testing Services Policy highlights that 
although the HIV status disclosure process on children found HIV-positive must not be 
rushed, “disclosure should happen before the child enters adolescence” (National 
Department of Health, 2016a: p.22). There is limited quantitative evidence on the latest 
prevalence of HIV status disclosure and its impact on ART outcomes among young 
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adolescents enrolled on ART in South Africa. The South African National Department of 
Health adopted UNAIDS’s ‘90-90-90 targets’ (SANAC, 2016). The targets were launched 
in 2014, and refer to the aims of diagnosing 90% of HIV-infected people through HIV 
testing and informing them of their HIV status, providing ART to 90% of people found to 
be HIV-positive and achieving viral load suppression on 90% of the infected people 
enrolled on ART - including pediatrics and adolescents by 2020 (UNAIDS, 2016; National 
Department of Health, 2016a). 
 
2.6 The prevalence of HIV status disclosure among children on ART 
A study on young adolescents on ART and enrolled in a disclosure intervention in 
Western Kenya found that only 40% knew their HIV status based on caregiver responses 
(Vreeman et al., 2015). Pinzón-iregui et al. (2013) reviewed 21 studies on the prevalence 
of HIV status disclosure among children below 15 years of age and enrolled on ART in 
various low, middle and high-income countries. They found that the median prevalence 
of full HIV status disclosure was 20% in low and middle-income countries, and 43% in 
high-income countries. They also found that the median age of full HIV status disclosure 
was 9 and 8 years respectively (Pinzón-iregui et al., 2013).  
 
Vreeman et al. (2014) and Atwiine et al. (2015) both found that a low percentage of 
children below 15 years of age enrolled on ART in low-to-middle income countries knew 
that they were HIV-infected compared to high-income countries. The World Bank (2017) 
ranks South Africa as one of the upper-middle income countries in Africa. Madiba (2012) 
found that the mean age of the fully disclosed children enrolled on ART in South Africa 
was 10.6 years. The average prevalence of HIV status disclosure among young 
adolescents enrolled on ART in sub-Saharan Africa is not clear.  
 
2.7 Impact of HIV status disclosure among adolescents on ART 
The evidence from some qualitative and quantitative studies in resource-limited countries 
reveals that there are both benefits and risks to HIV status disclosure among children 
enrolled on ART (Vreeman et al., 2013). Based on the World Health Organization 
Guidelines on HIV Disclosure Counselling for Children up to 12 Years of Age, HIV-
infected adolescents who know their status are likely to practice preventative behaviour 
that reduces HIV transmission to their sexual partners (WHO, 2011; WHO, 2013). The 
UNAIDS introduced the Guidance on HIV Prevention among Adolescent Girls and Young 
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Women in 2016; the guidance further highlighted that HIV-infected patients (including 
fully disclosed adolescents) adhering to an effective ART regime are up to 97% less-likely 
to transmit the virus (UNAIDS, 2016). 
 
Disclosure is recognised globally as an important factor that influences the ART 
outcomes among HIV-infected adolescents (WHO, 2011; National Department of Health, 
2016a). Age-appropriate HIV status disclosure is strongly associated with improved ART 
adherence and has been recognised as an essential means of reducing disease 
progression, onward transmission and mortality among African adolescents (Cluver et 
al., 2015; Brown et al., 2011; Haberer et al., 2011). 
 
Reports on post HIV status disclosure assessments in various countries indicate 
increased treatment adherence and improved clinical outcomes in some adolescents 
enrolled on ART, despite the feared risks of status disclosure (Pinzón-iregui et al., 2013; 
Vreeman et al., 2013). There are reasons to believe that HIV status disclosure on infected 
adolescents may lead to improved ART adherence, increased medication responsibility 
and better access to social support (WHO, 2011; Vreeman et al., 2014; National 
Department of Health, 2016a). HIV status disclosure builds child-to-healthcare provider 
and child-to-caregiver trust, both of which strengthen ART adherence (Wiener et al., 
2007). The assumption is that an adolescent enrolled on ART and who is aware of his/her 
status will take self-responsibility for ART adherence, which in turn will potentially lead to 
viral load suppression. 
 
A cross-sectional study on adolescents enrolled on ART in Western Kenya found that 
HIV status disclosure was associated with improved ART adherence (Vreeman et al., 
2014). Similar studies in Thailand, Zambia and Nigeria found improved ART adherence 
after HIV status disclosure in among adolescents enrolled on ART (Brown et al., 2011; 
Haberer et al., 2011; Cluver et al., 2015). A study in Romania found that undisclosed 
adolescents enrolled on ART have the highest risk of HIV disease progression, high viral 
load, declining CD4 count and death when compared to the disclosed counterparts 
(Sirikum et al., 2014). Studies in the United States and Zambia concluded that non-
disclosed adolescents enrolled on ART have increased levels of psychological distress, 
anxiety and depression, all of which negatively affect their ART outcomes (Haberer et al., 
2011; Cluver et al., 2015). 
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2.8 Conclusion and summary 
 
Adolescence is a crucial stage of a child’s life. It is during adolescence that important health 
choices are made that will have an impact on the rest of the individual’s life. The success of 
ART programmes in reducing HIV mortality among children that allows them to transit into 
adolescence implies that, HIV status disclosure is a necessary and important aspect of 
disease management that must be facilitated. HIV status disclosure has become an 
important factor to consider when it comes interventions on treatment, care and support of 
paediatrics and adolescents enrolled on ART in both low and high-income countries. Based 
on the studies done in Kenya, Thailand, Zambia and Nigeria, Romania and United States, 
there is evidence of associations between HIV status disclosure and ART outcomes among 
adolescents enrolled on ART. The largest ART programme in the world (which is in South 
Africa) provides a crucial context to draw and analyse a significant cohort of young 
adolescents enrolled on ART.  
 
Due to poor prioritization of the adolescent population in national HIV plans in low and 
middle-income countries, various studies indicate that the prevalence of HIV status 
disclosure among children enrolled on ART is generally low despite the existence of the 
World Health Organization Guidelines on HIV Disclosure Counselling for Children up to 12 
Years of Age. In line with the World Health Organization Guidelines on HIV Disclosure 
Counselling for Children up to 12 Years of Age, the South African National Department of 
Health has made important strides in developing local guidelines in the context of the 
country’s HIV pandemic. The National Disclosure Guidelines for Children and Adolescents 
in the context of HIV, TB and Non-Communicable Diseases is an important tool to guide 
healthcare workers and caregivers to conduct age-appropriate HIV status disclosure on 
children or adolescents enrolled on ART in South Africa. However, there is limited evidence 
of studies or analyses that have been conducted to review the implementation and impact 
of the HIV status disclosure guidelines for children in South Africa.  
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CHAPTER THREE  
 
 METHODOLOGY 
 
3.1 Introduction 
 
Chapter Two provided an overview of the findings from previous studies conducted 
elsewhere on the prevalence of HIV status disclosure among adolescents enrolled on ART. 
Furthermore, the chapter covered an outline of the key aspects of the HIV pandemic, ART 
programmes on paediatrics and adolescents, existing policies and guidelines for HIV status 
disclosure on children, as well as the concept of adolescence. Literature was also reviewed 
regarding the impact of HIV status disclosure on ART outcomes among adolescent patients. 
This chapter explains the activities and procedures followed in conducting this study. These 
activities include study design, research sites, the population used, ethical considerations, 
sampling, as well as how data was collected and analysed. 
 
3.2 Research design and methodology 
 
This study was a quantitative analysis of routinely collected ART monitoring data on a cohort 
of South African young adolescents enrolled on ART. ART monitoring data was obtained 
from the thirteen public healthcare clinics in the City of Johannesburg, Region A sub-district. 
The study also used secondary data extracted from the Johannesburg District Health 
Information System, Tier.net database and ART files kept at the clinics. The data consists 
of patients’ demographic information, HIV disclosure status, clinical and laboratory records 
of viral load count. The important variables analysed were HIV disclosure status, age, 
gender and ART outcomes - viral load count and clinic adherence. The extracted data was 
quantitatively analysed to determine the prevalence of HIV status disclosure among young 
adolescents enrolled on ART and measure the association between disclosure status and 
the ART outcomes. 
 
3.3 Quantitative research method 
 
Welman et al. (2005) indicates that there are two major research approaches, namely 
quantitative and qualitative approaches. The purpose of the quantitative approach - also 
known as the positivist approach - is to evaluate objective data consisting of numbers. On 
the other hand, the qualitative approach deals with subjective data that is acquired from the 
insights provided by respondents – this data is presented in language instead of numbers 
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(Welman et al., 2005). The quantitative approach uses a process of analysis that is based 
on complex structured methods to confirm or disapprove hypotheses. De Vos et al. (2005) 
indicate that qualitative approaches are those procedures that are not strictly formalised. 
 
3.3.1 Advantages of quantitative methods 
 
According to Family Health International (2005), the following are the main strengths of 
quantitative data collection: 
 numeric estimates 
 an opportunity for relatively uncomplicated data analysis 
 verifiable data 
 comparable data between different communities in different locations 
 data which does not require analytical judgement beyond consideration of how 
information will be presented in the dissemination process. 
 
3.3.2 Disadvantages of using quantitative methods 
 
Family Health International (2005) also identified the following weaknesses of quantitative 
data: 
 gaps in information, primarily because factors that are not included in the secondary 
data checklist will not be analysed.  
 labour intensive data collection process. 
 limited participation by affected persons in the direction of the data collection 
process. 
 
3.3.3 Justification for using a quantitative research approach 
 
This study adopted a quantitative research approach, based on the advantages of the 
approach to answer the aim and the objectives of the study. The study is aimed at 
determining the prevalence of HIV status disclosure among a representative South African 
population of young adolescents enrolled on ART. The study further seeks to evaluate the 
correlation between HIV status disclosure and ART outcomes, hence the quantitative 
approach was the most appropriate research method. 
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3.3.4 The use of secondary data 
Secondary data simply refers to existing, pre-collected and readily available quantitative 
data which may have been routinely collected by other individuals or for other programmes 
such as surveillance systems, service delivery, surveys, etc. (Boslaugh, 2007). Although 
secondary data might have been collected for different purposes, the data are accessible 
to researchers in order to answer or address research questions of interest. The ART-
related secondary data analysed in this study was routinely collected by public healthcare 
facilities as part of monitoring and evaluation of paediatrics and adolescents’ HIV services. 
The data was captured on patients’ ART files, stored on the Johannesburg District Health 
Information System and Tier.net. The use of secondary data in this study was determined 
by the convenient availability of the secondary data to answer the research aim, which is to 
conduct a situational analysis on the prevalence of HIV status disclosure among young 
adolescents enrolled on ART at public healthcare clinics. 
 
Table 3.1. Advantages and disadvantages of using secondary data (Boslaugh, 2007). 
Advantages  Disadvantages 
Data is usually processed and readily 
available. 
Tends to have large sample sizes because 
the data collection is comprehensive and 
routine. 
Time-saving, as data is presented in a 
ready-to-use format. 
Lack of control over data quality. 
Cost-efficient since the data is inexpensive 
to obtain. 
Data may be outdated or irrelevant. 
Data is collected over a longer period. This 
allows researchers to detect changes over 
time. 
There may be licence restrictions to using 
the data. 
Re-analysing secondary data potentially 
leads to new findings.  
 
 
3.4 Population 
 
3.4.1 Inclusion criteria 
 
This study used the ART monitoring data from a cohort of young adolescents between the 
ages of 10 and 14 years, and enrolled on ART in and before January 2018. The data was 
17 
 
obtained from public healthcare clinics in the City of Johannesburg, Region A. The young 
adolescents included both females and males. Only the patient files with consent forms 
completed by caregivers of the young adolescents were used. 
 
3.4.2 Exclusion criteria 
 
The study excluded young adolescents who were initiated on ART after January 2018 (less 
than a year ago) because they have short ART records. 
 
3.5 Sampling 
 
It is almost impossible to study an entire population of interest when all the members cannot 
be reached (De Vos et al., 2005). Using a convenient sampling method, secondary data on 
HIV disclosure status and ART records of all 281 young adolescents that met the inclusion 
criteria was collected from the public healthcare clinics in the City of Johannesburg, Region 
A. The Johannesburg District Health Information System had indicated that a total of 466 
young adolescents were enrolled on ART at the targeted public healthcare clinics by the 
end of June 2018. Out of the 466 young adolescents enrolled on ART, a cohort of 281 young 
adolescents met the inclusion criteria and the other 185 young adolescents were excluded 
based on the exclusion criteria. The use of secondary data was determined by the 
convenient availability of the secondary data to answer the research aim. 
 
3.6 Ethical considerations 
 
The ethical principles of informed consent, ethical research clearance, privacy and 
confidentiality were adhered to in this study. 
 
3.6.1 Informed consent 
Informed consent from the parents or caregivers of adolescents’ data used in this study was 
covered by a combination of the National Department of Health’s Index-Patient consent 
form (Appendix A), and the HIV services consent form (Appendix B): both tools are 
implemented by the Gauteng Department of Health in conjunction with the Johannesburg 
Health District. The National HIV Testing Services Policy (National Department of Health, 
2016a) recommends that the caregiver of every child being identified for HIV testing must 
sign the informed consent (Appendix A). The Gauteng Department of Health in conjunction 
with the Johannesburg Health District further implements the use of a combined HIV pre-
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test and pre-ART consent form (Appendix B). The latter form is administered for the actual 
HIV test on every person being tested, including children. According to the National 
Department of Health (2016a), routinely collected HIV-related data obtained from the 
records of local healthcare facilities are for the purposes of useful analysis. 
 
3.6.2 Research ethical clearance 
The study obtained formal ethical clearance (REC-01-63- 2018) from the University of 
Johannesburg’s Research Ethics Committee (Appendix C). Permission (Appendix D) to 
access healthcare facilities and use of the data on the District Health Information System 
was obtained from the Johannesburg Health District Research Committee (DRC Ref: 2018-
10-004). The Johannesburg District Research Committee strives to identify the district’s 
research priorities and to create a culture of research using data from the District Health 
Information System (AfroCP, 2018). The study was successfully registered on the South 
African National Health Research Database (NHRD Ref no: GP_201810_019). 
 
3.6.3 Privacy and confidentiality 
Privacy and confidentiality were protected and maintained during the study by not using the 
adolescents’ names or identity numbers. The sample data was de-identified from the 
adolescents’ names and unique codes were used. Only unique file numbers created at 
healthcare clinics were used to link the data from ART files to the Tier.net database and the 
Johannesburg District Health Information System. Data was stored in a password-protected 
folder on a password-protected laptop. 
 
3.6.4 Potential benefits 
There were no direct benefits to participants whose data was used in the study. However, 
the study findings provide evidence-based knowledge on the implementation of the South 
African National Disclosure Guidelines for Children and Adolescents in the context of HIV, 
TB and Non-Communicable Diseases. 
  
3.6.5 Potential risks 
The study targeted both disclosed and undisclosed adolescents. Seeking assent from 
undisclosed adolescents enrolled on ART had the risk of triggering accidental or unprepared 
HIV status disclosure when the purpose of assent had to be explained. A waiver on the 
requirement for adolescents’ assent was sought and granted from the University of 
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Johannesburg’s Research Ethics Committee. The granted waiver eliminated the risk of 
accidental and unprepared disclosure for the adolescents and any other individuals. The 
study did not put pressure on caregivers or infringe on their rights to disclose, thus the 
welfare of adolescents was less likely affected. Both the caregivers and the adolescents 
were not direct participants in the study, as the study only utilised secondary data. 
 
3.7 Data collection and recording  
 
The Johannesburg District Health Information System provided summary information such 
as the total number of young adolescents enrolled on ART per region or sub-district, and 
per healthcare clinic. To identify the HIV status disclosure, the researcher visited the 
targeted healthcare clinics and accessed the sample of ART files (as informed by the District 
Health Information System on how many young adolescents are enrolled on ART per clinic).  
 
The HIV status disclosure for adolescents enrolled on ART and their support group 
attendance records were found in their ART files kept at healthcare clinics. Appendix E 
shows the disclosure stamp used to record and update the stage of HIV status disclosure 
in the adolescent’s ART files at the clinics. The stages start from pre-disclosure to post-
disclosure (the full meanings of the disclosure symbols are listed in Appendix E). 
 
Partial HIV status disclosure means explaining to the infected child about germs without 
mentioning or naming it HIV, what germs can do to the immune system, the role of solider 
cells and how medicine helps the solider cells to fight the germ. On the other hand, full 
HIV status disclosure is when the HIV virus is mentioned and explained to the infected 
child so that he/she acquires full knowledge of his/her HIV status (Right to Care, 2018). 
 
The data on ART outcomes (viral load count and clinic adherence), period on ART and 
demographic information for each young adolescent was accessed on the Tier.net system. 
Tier.net is a real-time electronic system on which detailed ART history and records of every 
patient are captured and stored directly from the ART files. The Tier.net system was more 
reliable than ART files because some important pages from the clinics’ ART records were 
often found missing in files. Patient information was only linked from the ART files to the 
Tier.net system using unique identifiers such as file numbers. The data on the following 
variables were collected and captured in an Excel spreadsheet: 
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Table 3.2. Variables targeted 
Categorical Variables and Coding  Continuous Variables 
HIV status disclosure –  
1 Partially disclosed 
2 Fully disclosed 
 
Current Age (in years) 
 
Gender –  
1 Female 
2 Male 
 
Viral load count (copies/ml) 
 
Support group attendance –  
1 Yes 
2 No 
 
Period on ART (in years) 
 
Clinic Adherence –  
0 Deceased 
1 Defaulted/Loss-to-follow 
2 Adhering to clinic appointments  
 
 
 
3.8 Statistical data analysis 
 
The collected data was captured and coded for analysis using the IBM Statistical 
Package for Social Sciences (SPSS) Version 25. Quantitative data analyses were 
conducted to determine the prevalence of HIV status disclosure among a sample of 
young adolescents enrolled on ART, as well as to determine the correlation between 
disclosure status and ART outcomes.  
  
3.8.1 Frequencies and summary statistics  
 
The findings from the continuous variables (current age, viral load count and period on ART) 
were presented in tables. Figures were converted into percentages, frequencies, summary 
statistics and measures of central tendency - including the mean and median of continuous 
variables. 
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3.8.2 Pearson`s chi-square tests of independence 
 
Pearson’s chi-square tests of independence was used to measure the several associations 
between the categorical variables (HIV status disclosure, gender, support group attendance 
and clinic adherence). A p–value below 0.05 was considered to be statistically significant.  
 
3.8.3 Multiple linear regression analysis 
 
Multiple linear regression analysis was performed to determine if HIV status disclosure, age, 
gender, support group attendance and period on ART influences viral load count and clinic 
adherence. 
 
3.9 Validity and reliability 
 
A significant increase in the number of children enrolled on ART and surviving into 
adolescence in South Africa made the cohort and methodology of this study highly relevant. 
The young adolescence band used in this study and their characteristics (age, gender 
duration on ART and viral load count) represent a typical cohort of young adolescents living 
with HIV and enrolled on ART in South Africa. The utilisation of routinely collected ART 
monitoring data from public healthcare systems enables the findings of the study to be 
broadly generalised. A standardised analysis of routinely collected ART monitoring data that 
considers heterogeneous disclosure statuses among young adolescents enrolled on ART 
facilitates a valid and reliable study. Moreover, a key strength of this cohort analysis is the 
number of participants’ data accessed from the thirteen public healthcare clinics in the City 
of Johannesburg, Region A.  
 
3.10 Conclusion and summary 
 
In line with the aim and objectives of this study, a quantitative research approach was 
adopted, and secondary data extracted from the Johannesburg District Health System, 
Tier.net and ART files from the targeted public healthcare clinics was used. The key 
principles of research ethics were considered and adhered to in order to prevent any 
harm and potential risks to the sample population.  
 
The collected data was analysed to quantitatively determine the prevalence of HIV status 
disclosure on a cohort of young adolescents enrolled on ART at the thirteen public 
healthcare clinics in the City of Johannesburg, Region A. Other variables such as gender, 
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current age, period on ART, support group attendance and clinic adherence were 
analysed in relation to HIV status disclosure and viral load count. The data was analysed 
using the IBM SPSS Version 25. A significance level of 0.05 was used, and a p-value 
below 0.05 was considered statistically significant. 
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CHAPTER FOUR  
 
RESULTS, INTERPRETATION AND DISCUSSION 
 
4.1 Introduction 
 
This chapter outlines the results of data analysis, interpretation and discussions to fulfil 
the aim and objectives of this study. The study aimed to conduct a situational analysis to 
determine the prevalence of HIV status disclosure among young adolescents enrolled on 
ART in the South African context. This chapter also explores the key variables that 
influence the prevalence of HIV status disclosure. Furthermore, the chapter discuss the 
results on the analysis that evaluated the correlation between HIV status disclosure and 
the major ART outcomes – viral load count and clinic adherence.  
 
The following key variables were selected and analysed: HIV status disclosure, gender, 
support group attendance, clinic adherence, current age, period on ART and viral load 
count. The selection of these variables was based on a literature review of studies related 
to HIV prevalence, HIV status disclosure and ART management in adolescent patients. 
The discussion and interpretation of results in this chapter are juxtaposed to the literature 
review. Although the results can be generalised to a typical cohort of young adolescents 
enrolled on ART, they are mainly based on the selected sample of secondary ART data 
and demographic information of 281 young South African young adolescents enrolled on 
ART at the clinics located in the City of Johannesburg, Region A. 
 
4.2 Data summary - healthcare facilities 
 
Table 4.1 below indicates the summary of data collected from the thirteen public 
healthcare facilities in the City of Johannesburg, Region A. The healthcare clinics with a 
high percentage of young adolescents enrolled on ART are: Thutukani, Ebony, 
Bophelong, Hikhensile, Mpumelelo, Rabie Ridge and Mayibuye. These clinics are in Ivory 
Park and very close to Tembisa, and they are also communities characterised by a high 
population density and large informal settlements. As indicated in the literature review, in 
and around South African urban informal settlements there is a higher risk of exposure 
to HIV which contributes to high HIV prevalence (SANAC, 2016; National Department of 
Health, 2016a). The healthcare clinics with the lowest number of young adolescents 
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enrolled on ART are Nizamiya and Halfway House. These clinics are located in Midrand 
which is characterised by a low population density and mainly formal settlements. 
 
Table 4.1. Healthcare facilities accessed 
Name of health facility Number of young adolescents’ records used Percent (%) 
Bophelong clinic 30 10.7 
Diepsloot South clinic 8 2.8 
Ebony clinic 33 11.7 
Eyethu clinic 14 5 
Halfway House clinic 6 2.1 
Hikhensile clinic 28 10 
Mayibuye clinic 18 6.4 
Midrand West clinic 13 4.6 
Mpumelelo clinic 26 9.2 
Nizamiya clinic 5 1.8 
OR Tambo clinic 11 3.9 
Rabie Ridge clinic 19 6.8 
Thutukani clinic 70 25 
Total 281 100 
 
4.3 Selected categorical variables 
The categorical variables considered in this section are as follows: HIV status disclosure, 
gender, support group attendance and clinic adherence. 
 
4.3.1 HIV status disclosure 
Table 4.2 below shows the categorisation of young adolescents enrolled on ART between 
the partially disclosed and fully disclosed.  
 
Table 4.2. Prevalence of HIV status disclosure 
HIV disclosure status Frequency Percent (%) 
Partially Disclosed 207 73.7 
Fully Disclosed 74 26.3 
Total 281 100 
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As shown in Table 4.2 above, the prevalence of HIV status disclosure among the sample 
of the young adolescents enrolled was found to be relatively low at 26.3% (fully 
disclosed). The majority (73.7%) of young adolescents in the sample were not fully 
disclosed, they were found only partially disclosed. These results imply that within the 
cohort of young adolescents enrolled on ART in South Africa, less than a third of them 
are fully aware that they are HIV positive. The remaining majority only know that they are 
taking chronic treatment but are not aware that they are HIV-infected.  
 
The South African National HIV Testing Services Policy and the National Disclosure 
Guidelines for Children and Adolescents in the context of HIV, TB and Non-
Communicable Diseases both advice that full HIV status disclosure to a child enrolled on 
ART must happen before the onset of adolescence (National Department of Health, 2016a; 
National Department of Health, 2016b). The WHO Disclosure Guidelines on HIV 
Disclosure Counselling for Children up to 12 Years of Age also recommends that children 
enrolled on ART must be fully disclosed about their HIV status before the age of 12 years 
(WHO, 2011).  
 
The results in Table 4.2 point out that there is a challenge that is hindering the achievement 
of the guidelines’ target on HIV status disclosure as most of the young adolescents enrolled 
on ART were found not aware of their HIV status. These results resemble the findings by 
Vreeman et al. (2014) and Atwiine et al. (2015), they both found that a small percentage 
of children below 15 years of age and enrolled on ART in low-to-middle income countries 
were fully disclosed. Madiba (2012) also found that a relatively small number of HIV-
infected South African children enrolled on ART and below the age of 14 years knew their 
HIV status. 
 
4.3.2 Gender distribution 
 
Table 4.3. Gender frequency among young adolescents on ART 
Gender Distribution Percent (%) 
Female 151 53.7 
Male 130 46.3 
Total 281 100 
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The results in Table 4.3 above show that out of the 281 young adolescents in the sample, 
girls made up the majority while boys were in the minority. The sample consisted of 151 
(53.7%) adolescent girls and 130 (46.3%) adolescent boys. These results correspond 
with the literature review, which indicated that a typical cohort of HIV-infected young 
adolescents enrolled on ART in South Africa tends to have more girls than boys (National 
Department of Health, 2016a). Kranzer et al. (2017) highlighted that in the cohorts of HIV-
infected children below 10 years of age, gender tends to be relatively balanced because 
of perinatal infection. On the other hand, there is an increased proportion of girls in 
cohorts of HIV-infected adolescents due to sexual risks (Kranzer et al., 2017). 
 
4.3.3 HIV status disclosure and Gender 
 
The table below shows the prevalence of HIV status disclosure by gender segregation. 
 
Table 4.4. Crosstabulation between HIV status disclosure and gender 
 Gender 
HIV disclosure status Female Male Total 
Partially disclosed, n (%) 110 (53.1%) 97 (46.9%) 207 
Fully disclosed, n (%) 41 (55.4%) 33 (44.6%) 74 
Total 151 130 281 
 
The results in Table 4.4 above indicate that the prevalence of full HIV status disclosure 
in the cohort of young adolescents enrolled on ART is higher (55.4%) on young 
adolescent girls compared to boys (44.6%). The results correspond with literature review 
which highlights that there is gender-related psychosocial dynamic during adolescence - 
girls tend to mature earlier than boys (Vreeman et al., 2014). Vreeman et al. (2014) further 
noted that within the same age group of HIV-infected young adolescents and enrolled on 
ART, those who develop maturity earlier tend to know their HIV status (fully disclosed) 
earlier compared to their less matured counterparts. 
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Table 4.5. Chi-Square test between HIV status disclosure and gender 
 
Value df 
Asymptotic Significance 
(2-sided) 
Pearson Chi-Square 1.539 1 0.215 
N of Valid Cases 281   
 
 
Table 4.5 above shows the results of a Chi-Square test used to analyse the relationship 
between HIV status disclosure and gender. Interestingly, the result in Table 4.5 is not 
statistically significant (p=0.215). While a larger proportion of girls had full HIV status 
disclosure than boys, this difference was not statistically significant. The results show that 
there is no statistically significant association between gender and HIV status disclosure 
(p=0.215). Gender is almost equally balanced among both partially disclosed and fully 
disclosed young adolescents enrolled on ART.  
 
4.3.4 Support group attendance 
Table 4.6 below illustrates the frequency of support group attendance by young 
adolescents enrolled on ART. 
 
Table 4.6. Support group attendance by young adolescents on ART 
Attended support group Frequency Percent (%) 
Yes 203 72.2 
No 78 27.8 
Total 281 100 
 
The results in Table 4.6 above indicate that the majority (72.2%) of young adolescents in 
the sample attended the support group, whilst only 27.8% did not attend. Support group 
attendance is closely related to clinic adherence. Support groups for young adolescents 
enrolled on ART regularly take place on the same day when adolescents visit healthcare 
facilities, i.e. on the same day as their given clinic appointments. Therefore, young 
adolescents who adhere to clinic appointments manage to attend support group, while 
those who do not adhere to clinic appointments miss the opportunity to attend support 
group.  
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4.3.5 HIV status disclosure and Support group attendance 
 
As shown by the results in Table 4.6 (above), a majority (72.2%) of the young adolescents 
enrolled on ART are attending support group at healthcare facilities, despite their 
variability in HIV disclosure status. The partially disclosed young adolescents are also 
among those attending support group, and this is because there are two categories of 
support groups running at healthcare facilities for young adolescents enrolled on ART. 
The partially disclosed support groups are separated from the fully disclosed support 
groups (Right to Care, 2018). The support group facilitators always conduct screenings 
on the young adolescents to avoid combining the undisclosed and disclosed young 
adolescents in the same support group. 
 
The table below shows the relationship between HIV status disclosure and support group 
attendance. 
Table 4.7. Crosstabulation between HIV status disclosure and support group attendance 
 Attend support group 
HIV disclosure status Yes No Total 
Partially disclosed, n (%) 141 (68.1%) 66 (31.9%) 207 
Fully disclosed, n (%) 62 (83.8%) 12 (16.2%) 74 
Total 203 78 281 
 
 
The results in Table 4.7 indicate that among young adolescents who attend support 
group, the prevalence of HIV status disclosure is very high (83.8%), as compared to a 
prevalence of 16.2% among those who are not attending support group. 
 
The following table shows the results of a Chi-Square test between HIV status disclosure 
and support group attendance. 
 
Table 4.8. Chi-Square test between HIV status disclosure and support group attendance 
 Value df Asymptotic Significance (2-sided) 
Pearson Chi-Square 9.164 1 0.002 
N of Valid Cases 281   
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The Chi-square test results in Table 4.8 shows that there is an association between HIV 
status disclosure and attending support groups, and this association is statistically 
significant (p=0.002). The fully disclosed young adolescents enrolled on ART frequently 
attend support group at healthcare facilities. 
 
4.3.6 Clinic adherence 
The table below indicates the frequency of clinic adherence by young adolescents 
enrolled on ART at public healthcare facilities. 
 
Table 4.9. Clinic adherence among young adolescents on ART 
Clinic adherence Frequency Percent 
Dead 2 0.7 
Defaulted/Loss to Follow 81 28.8 
Adhering to Clinic Appointments 198 70.5 
Total 281 100 
 
As shown by the results in Table 4.9 above, a majority (70.5%) of the young adolescents 
enrolled on ART are adhering to clinic appointments for clinical monitoring, attending 
support group and collecting treatment as booked. The high rate of clinic adherence can 
be attributed to the involvement of caregivers, who ensure that young adolescents arrive 
at healthcare facilities as per scheduled bookings. However, Sawyer et al. (2012) indicated 
that during early adolescence, the extent of caregivers’ involvement in adolescents’ 
healthcare tends to gradually decrease, i.e. the adolescent takes self-responsibility for clinic 
adherence. Hence, the results in Table 4.9 further indicate that 28.8% of young adolescents 
enrolled on ART have records of defaulting and missing clinic appointments for ART 
monitoring. Only 0.7% of the sample died in the last two years while enrolled on ART. As 
indicated in the literature review, Cluver et al. (2015) found that the low prevalence of 
mortality among HIV-infected young adolescents enrolled on ART is attributed to the 
improved and effective ART programmes for paediatrics and adolescents in South Africa. 
 
4.3.7 HIV status disclosure and Clinic adherence 
Table 4.10 below shows the relationship between HIV status disclosure and clinic 
adherence among young adolescents enrolled on ART. The results show that the majority 
of young adolescents in the sample are adhering to clinic appointments despite the 
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variability in HIV disclosure status. Among the young adolescents adhering to clinic 
appointments, the prevalence of HIV status disclosure is high (70.3%), in comparison to 
29.7% among those not adhering to clinic appointments. This can be attributed to the fact 
that when young adolescents enrolled on ART frequently visit healthcare facilities, they 
find out either formally or informally on their own (and in a variety of ways) that they are 
HIV-infected and enrolled on HIV treatment. 
 
Table 4.10. Crosstabulation between HIV status disclosure and clinic adherence 
 Clinic adherence 
HIV disclosure status Dead Defaulted/Loss 
to follow 
Adhering to clinic 
appointments 
Total 
Partially disclosed, n (%) 2 (1%) 59 (28.5%) 146 (70.5%) 207 
Fully disclosed, n (%) 0 22 (29.7%) 52 (70.3%) 74 
Total 2 81 198 281 
 
Table 4.11 below shows the results of a Chi-Square test between HIV status disclosure 
and clinic adherence. The results are not statistically significant (p=0.598), suggesting 
that there is a weak relationship between HIV status disclosure and clinic adherence. 
Young adolescents tend to equally adhere to clinic appointments despite their HIV 
disclosure status, probably because of the involvement of responsible caregivers who 
ensure that adolescent patients are brought to clinics on scheduled appointment dates. 
 
Table 4.11. Chi-Square test between HIV status disclosure and clinic adherence 
 Value df Asymptotic Significance (2-sided) 
Pearson Chi-Square 1.028 2 0.598 
N of Valid Cases 281   
 
 
4.4 Selected continuous variables 
The continuous variables considered in this section are as follows: current age, period on 
ART and viral load count. 
 
4.4.1 Age Composition 
Table 4.12 below shows a breakdown of age composition on the sample cohort of young 
adolescents between 10 and 14 years of age. 
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Table 4.12. Age composition among the sample of young adolescents 
Age (years) Frequency Percent (%) 
10 59 21 
11 43 15.3 
12 55 19.6 
13 65 23.1 
14 59 21 
Total  281 100 
 
 
The results in Table 4.12 indicate that young adolescents who are currently 13 years of 
age form the majority (23.1%) of the sample, followed by 10-year olds (21%) and 14-year 
olds (21%). Adolescents who are 11 years of age were least represented (15.3%) in the 
sample, followed by 12-year olds (19.6%) and 12-year olds (17.5%). As indicated in the 
literature review, the South African National Department of Health is coordinating the 
provision of effective ART programmes to children found HIV-positive, and most of the 
children are surviving into early adolescence when enrolled on ART (Cluver et al., 2015). 
However literature indicates that some HIV-infected young adolescents enrolled on ART 
become defaulters or loss-to-follow patients during middle adolescence (Kasedde et al., 
2014). 
 
4.4.2 Age and HIV status disclosure 
 
As shown by the results in Table 4.13 below, this study found that the mean age of full 
HIV status disclosure among young adolescents enrolled on ART is 13.6 years. When 
compared to the findings cited in the literature review, this mean age of 13.6 years for full 
HIV status disclosure has increased from what Madiba (2012) found. Madiba (2012) 
found that the mean age of disclosed children on ART in South Africa was 10.6 years. 
 
On the other hand, Pinzón-iregui et al. (2013) found that the median age of HIV status 
disclosure among children below 15 years of age enrolled on ART was 9 years in low-to-
medium income countries. These disparities are attributed to the fact that different age 
bands on children or adolescents were used in each of these studies. The literature 
review also confirms that various cohort studies on HIV-infected children use the age 
range of 0–15 years. Kranzer et al. (2017) recommends that studies with analytical 
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approaches for age-related cognitive and psychosocial development on children must 
use narrow age-bands. 
 
The table below indicates the results of an independent-samples t-test comparing the 
mean current age between the partially disclosed and fully disclosed young adolescents 
enrolled on ART. 
 
Table 4.13. Independent samples t-test between Age and HIV status disclosure 
 HIV disclosure status Mean age 
Current Age Partially Disclosed 11.82 
Fully Disclosed 13.62 
 
 
 
The independent samples t-test results in Table 4.13 above are statistically significant 
(p=0.000). There is a significant difference between the current mean ages mean for the 
two HIV status disclosure categories (p<0.05). The mean age of the partially disclosed 
young adolescents was significantly lower (M = 11.8 years, sd = 1.513) than the mean 
age of the fully disclosed (M = 13.6 years, sd = 1.113). This implies that the age of a 
young adolescent enrolled on ART was found to influence their HIV status disclosure - 
young adolescents above 13 years of age have a high prevalence of full HIV status 
disclosure when compared to those below the age of 13 years. This may also suggest 
that in this population, HIV status disclosure is more likely done when the children are 
older. As highlighted in the literature review, during the transition from childhood to early 
adolescence, HIV status disclosure to young adolescents enrolled on ART remains a 
challenge for both caregivers and healthcare workers (National Department of Health, 
2016b). 
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4.4.3 Period on ART 
Figure 4.1 below shows the distribution of the period on ART in years for the sample of 
HIV-infected young adolescents. The results show a median period of 6 years on ART 
and a standard deviation of 3.947. The histogram is skewed right, indicating that the data 
for this variable is not normally distributed. Furthermore, the results show that 81 young 
adolescents were enrolled on ART in the last two years alone, only 18 have been on ART 
for more than 12 years and the other majority adolescents in the sample have been on 
ART for a period of between 3 to 12 years. 
 
Figure 4.1. Period on ART distribution 
 
 
The high number of HIV-infected young adolescents who have been enrolled on ART in 
the last two years can be attributed to the combined and scaled-up efforts by the South 
African Department of Health and supporting partners to meet the UNAIDS ‘90-90-90’ 
targets by the year 2020. As indicated in the literature review, the ‘90-90-90’ strategy 
targets are: diagnosing 90% of HIV-infected people; enrolling on ART 90% of the people 
found to be HIV-positive; and achieving viral load suppression on 90% of people enrolled 
on ART - including pediatrics and adolescents (National Department of Health, 2016a; 
UNAIDS, 2016; SANAC, 2016). The first and second ‘90’s refer to intensified efforts to 
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find new cases of HIV-infected children and ensuring that when they are found, they are 
immediately enrolled on ART (National Department of Health, 2016a). 
 
4.4.4 Period on ART and HIV status disclosure 
The table below indicates the results of an independent samples t-test comparing the 
mean years enrolled on ART between partially disclosed and fully disclosed young 
adolescents. 
 
Table 4.14. Independent samples t-test between Years on ART and HIV status disclosure 
 HIV disclosure status Mean 
Years On ART Partially Disclosed 5.62 
Fully Disclosed 6.18 
 
 
 
The results in Table 4.14 above are statistically significant (p=0.023). However, the 
difference between the mean enrolled years on ART for the fully disclosed and partially 
disclosed is very small. The mean years enrolled on ART for partially disclosed young 
adolescents was found to be lower (M = 5.6 years, sd = 3.310) than the mean of fully 
disclosed (M = 6.1 years, sd = 3.863). This implies that the period enrolled on ART for 
young adolescents has little influence HIV status disclosure. 
 
4.4.5 Viral load count results 
The summary results on viral load count cases in Table 4.15 below show that 93.6% of 
the young adolescents enrolled on ART had updated records on viral load count, while 
6.4% had missing or outdated records. Table 4.15 below shows the case summary on 
viral load count records used for this study. 
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Table 4.15. Viral load count results - case processing summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Viral load count 263 93.6% 18 6.4% 281 100% 
 
The missing 6.4% viral load count records on some young adolescents enrolled on ART 
can be attributed to poor filing at healthcare facilities. Most of the ART files found at the 
healthcare facilities had stickers indicating that blood samples from the young 
adolescents were taken by clinicians for laboratory viral load count, but the results were 
not recorded or filed. Table 4.16 below shows the descriptive statistics on the viral load 
count records for the study sample.  
 
Table 4.16. Viral load count descriptive statistics 
 Statistic 
Viral load count Mean 13292.42 
Median 119.00 
Minimum 15 
Maximum 457000 
 
As indicated by the results in Table 4.16 above, a mean viral load count of 13292.42 
copies/mL, a median of 119 copies/mL and a standard deviation of 52641.51 were found 
among the sample of young adolescents enrolled on ART. A minimum viral load count of 
15 copies/mL and a maximum of 457000 copies/mL were also found. 
 
The Table 4.17 below shows that only 24.7% of the young adolescents have a 
suppressed viral load count (below 20 copies/mL), while the remaining majority are 
unsuppressed (above 20 copies/mL). 
 
Table 4.17. Viral load suppression 
 
 
 
Viral load count 
results 
 N Percent (%) 
Suppressed/undetectable results 
(<20 copies/ml) 
65 24.7 
Unsuppressed/detectable results 
(>20 copies/ml) 
198 75.3 
Total 263 100 
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The results in table 4.17 above showing that the majority (75.3%) of young adolescents 
enrolled on ART are not virally suppressed, corresponds with the WHO findings on 
management in the adolescent population enrolled on ART in South Africa. The WHO 
(2013) noted that there is inadequate support for adolescents enrolled on ART to remain 
in care, adhere to treatment and achieve constant viral load suppression. The UNAIDS 
(2017) concluded that HIV-related deaths among adolescents in South Africa during the 
period between 2005 and 2012 increased by 50% due to disease progression or high 
viral load. 
 
4.4.6 Viral load count and HIV status disclosure 
As indicated in Table 4.18 below, the results of an independent samples t-test comparing 
the mean viral load count between the partially disclosed and fully disclosed are not 
statistically significant (p=0.886). The mean viral load count for the partially disclosed 
young adolescents was found to be a little lower (M = 13155.79 copies/mL, sd = 
50520.987) than the mean viral load count for the fully disclosed (M = 13589.20 
copies/mL, sd = 57263.089). The results show a small difference between the mean viral 
load count for the two categories (t (293) = -.066, p>0.05). This shows that there is no 
correlation between HIV disclosure status and viral load count. The results of this study 
are in contrast to the assumption that HIV status disclosure is strongly associated with 
improved ART adherence among HIV-positive adolescents and reduces disease 
progression as according to Wiener et al. (2007), Brown et al. (2011), Haberer et al. 
(2011), Sirikum et al. (2014) and Cluver et al. (2015). 
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Table 4.18. Independent samples t-test between Viral load count and disclosure status 
 HIV disclosure status Mean 
Viral load count Partially Disclosed 13155.79 
Fully Disclosed 13589.20 
 
 
 
The results in Table 4.18 above validate some of the findings in the literature review. Young 
adolescents are characterised by unstable behaviour and immature cognitive functioning, 
thus they often find it difficult to consistently adhere to long-term medication such as ART, 
even if they are fully disclosed of their HIV status (Jaspan et al., 2009; Sawyer et al., 2012; 
Hanghøj & Boisen, 2014). Kranzer et al. (2017) further confirms that poor ART adherence 
among young adolescents enrolled on ART is often experienced in both low and high-
income countries. Hence this study found that the majority of young adolescents enrolled 
on ART are not virally suppressed, even if they are fully disclosed. The WHO Guidelines 
on HIV Status Disclosure for Children up to 12 Years of Age, confirms that HIV-infected 
young adolescents who are fully disclosed are likely to only practice preventative 
behaviour that reduces HIV transmission to their sexual partners (WHO, 2011; WHO, 
2013).  
 
4.5 Conclusion and summary of findings 
 
The results of this study showed an overall low (26.3%) prevalence of full HIV status 
disclosure among young adolescents enrolled on ART in South Africa. However, further 
analyses have indicated variant results on the relationship between HIV status disclosure 
and other variables such as gender, support group attendance and clinic adherence. Girls 
tend to be a majority in the cohort of young adolescents enrolled on ART, and they also 
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have a high prevalence of HIV status disclosure than boys. Majority of young adolescents 
attending support groups and adhering to clinic appointments are fully disclosed.  
 
The viral load count is the major variable used as a key outcome of ART on HIV-infected 
patients. Among the young adolescents used in the sample, a minimum viral load count 
of 15 copies/mL and a maximum of 457000 copies/mL was found. 75.3% of the young 
adolescents enrolled on ART were found with unsuppressed/detectable viral load count 
(above 20 copies/mL), despite the HIV disclosure status. The difference in mean viral 
load count between the partially disclosed young adolescents and the fully disclosed was 
found not statistically significant. The young adolescents who are partially disclosed had 
lower mean viral load count than fully disclosed adolescents, yet the difference was very 
small. This study concludes that statistically, there is no correlation between HIV status 
disclosure and viral load count among young adolescents enrolled on ART. 
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CHAPTER FIVE  
 
 CONCLUSIONS AND RECOMMENDATIONS 
 
 
5.1 Introduction 
 
This study was undertaken to determine the prevalence of HIV status disclosure and to 
evaluate the correlation between status disclosure and ART outcomes among young 
adolescents enrolled on ART at public healthcare facilities in the City of Johannesburg, 
Region A.  
 
In order to provide a background and to validate the findings of this study, literature was 
reviewed in Chapter Two on key aspects related to HIV, ART and HIV status disclosure 
in adolescents. The following key aspects across the global and South African context 
were outlined: overview of HIV prevalence and ART-related trends; adolescence; the 
general impact of HIV status disclosure on treatment outcomes; HIV status disclosure 
guidelines and the prevalence of HIV status disclosure among young adolescents enrolled 
on ART. The various studies highlighted in the literature review revealed that generally, 
there is a low prevalence of HIV status disclosure among young adolescents enrolled on 
ART across low, middle and high-income countries. Furthermore, various studies 
explored in the literature review highlighted that full HIV status disclosure among young 
adolescents enrolled on ART is necessarily important, contributes to improved adherence 
and better ART outcomes. 
 
Significant aspects of the research methodology used, the targeted population and 
sampling method; ethical considerations; variables, data collection methods and data 
analysis processes were covered in Chapter Three. The research methodology followed 
a quantitative research design; this choice was justified based on the study aim, which 
sought to evaluate objective data consisting of numbers and prevalence data. In order to 
achieve the objectives of this study, the data was analysed using IBM SPSS Version 25. 
A significance level of 0.05 was used, and a p-value below 0.05 was considered 
statistically significant in the univariate analysis.  
 
The following key variables were used: HIV status disclosure, gender, support group 
attendance, clinic adherence, age, period on ART and viral load count. Categorical 
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variables, i.e. HIV status disclosure, gender, support group attendance and clinic 
adherence were coded into objective data consisting of numbers for quantitative analysis. 
Besides the categorical variables data, secondary data such as period on ART and viral 
load count from routinely collected information at clinics, was obtained from the 
Johannesburg District Health Information System, Tier.net and the ART files kept at the 
targeted healthcare clinics.  
 
This chapter concludes the entire study and gives possible recommendations to improve 
the prevalence of HIV status disclosure among young adolescents enrolled on ART, in 
line with the World Health Organization Guidelines on HIV Disclosure Counselling for 
Children up to 12 Years of Age, and the South African National Disclosure Guidelines for 
Children and Adolescents in the context of HIV, TB and Non-Communicable Diseases. 
This study also adds evidence-based knowledge to the existing local literature on the 
subject matter. 
 
5.2 Conclusion 
 
The WHO Disclosure Guidelines on HIV Disclosure Counselling for Children up to 12 
Years of Age clearly recommends that HIV status disclosure to a child enrolled on ART 
must happen between the ages of 6 and 12 years. Alternatively, the South African 
National Disclosure Guidelines for Children and Adolescents in the context of HIV, TB 
and Non-Communicable Diseases recommends that HIV status disclosure must happen 
before the child enrolled on ART enters adolescence. Based on the data analysis results 
obtained from this study, it was found that there is a low prevalence of full HIV status 
disclosure among the South African cohort of young adolescents enrolled on ART. Only 
26.3% of the young adolescents enrolled on ART were found fully disclosed. The other 
73.7% have passed the recommended ages at which full HIV status disclosure should 
have taken place, they are still only partially disclosed. 
 
The literature reveals that in other studies conducted elsewhere, the prevalence of HIV 
status disclosure among young adolescents enrolled on ART is generally lower, despite 
the existence of the WHO Disclosure Guidelines on HIV Disclosure Counselling for 
Children up to 12 Years of Age. Although the HIV status disclosure prevalence is lowest 
in low and middle-income countries, the prevalence is generally low across low, middle 
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and high-income countries (Pinzón-iregui et al., 2013; Vreeman et al., (2014); Atwiine et 
al., 2015). Literature on previous studies conducted elsewhere on the prevalence of HIV 
status disclosure among the young adolescents enrolled on ART corresponds with the 
findings of this study conducted within the South African context. Therefore, there is a 
need for intervention on caregivers and healthcare workers to ensure that children 
including young adolescents enrolled on ART are fully disclosed in line with the existing 
WHO and local disclosure guidelines.  
 
This study explored gender and age as common variables that affect the HIV status 
disclosure variances among young adolescents enrolled ART. The study found a higher 
percentage of girls than boys in the cohort of young adolescents enrolled on ART and 
this corresponds with other previous studies. It follows that the prevalence of full HIV 
status disclosure was found higher (55.4%) in young adolescent girls than their male 
counterparts (44.6%). Based on age, this study found that young adolescents above 13 
years of age have a higher prevalence of full HIV status disclosure compared to those 
below the age of 13 years. The study found that the mean age of full HIV status disclosure 
among young adolescents enrolled on ART in South Africa is 13.6 years. 
 
To evaluate the correlation between HIV status disclosure and ART outcomes, the study 
focused on viral load count results. This study found that despite the HIV disclosure 
status, 75.3% of the young adolescents enrolled on ART are not virally suppressed 
(above 20 copies/mL); only 24.7% have suppressed viral load count (below 25 
copies/mL). The results also show a small difference between the mean viral load count 
for the partially and fully disclosed young adolescents (t (293) = -.066, p >0.05). The study 
found that there is a very weak correlation between HIV status disclosure and viral load 
count. This specific finding invalidated the assumption that full HIV status disclosure is 
strongly associated with reduced disease progression among young adolescents 
enrolled on ART. This study concurs with Sawyer et al. (2012) who pointed that due to 
unstable behaviour and immature cognitive functioning, young adolescents often find it 
difficult to adhere consistently to the long-term ART treatment required to achieve viral load 
suppression, despite the HIV disclosure status. Hence, the majority of young adolescents 
enrolled on ART including the fully disclosed are not virally suppressed. 
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However, this study found that the prevalence of full HIV status disclosure is high (70.3%) 
among the young adolescents adhering to clinic appointments for ART appointments, 
and low (29.7%) among those not adhering to clinic appointments. Therefore, there is a 
relationship between clinic adherence and HIV status disclosure, disclosure being 
strongly affected by clinic adherence. The young adolescents who frequently visit 
healthcare facilities for ART monitoring, attend support group and collect treatment tend 
to be fully disclosed earlier. 
 
5.3 Recommendations 
 
The discussion in this section will focus on recommendations based on the findings of 
this study. The recommendations are as follows: conduct baseline survey on HIV status 
disclosure among young adolescents enrolled on ART; assessments of caregivers and 
healthcare workers’ capacity to conduct full HIV status disclosure on children including 
young adolescents; and on-going capacity building on healthcare workers.  
 
5.3.1 Baseline survey on HIV status disclosure 
To measure the impact of any intervention aimed at improving the prevalence of HIV 
status disclosure, healthcare providers must conduct full survey on young adolescents 
enrolled on ART at public healthcare facilities. The survey will help to verify if HIV status 
disclosure is correctly recorded and updated in the ART files; and the survey results will 
be used to establish baseline data. 
 
5.3.2 Assessments of caregivers and healthcare workers 
The results of this study indicate that there is a low prevalence of HIV status disclosure 
among young adolescents enrolled on ART. The South African National Disclosure 
Guidelines for Children and Adolescents in the context of HIV, TB and Non-
Communicable Diseases are designed to guide caregivers and healthcare workers to 
conduct age-appropriate and health-promoting HIV status disclosures on children 
(National Department of Health, 2016b). It is therefore important that healthcare providers 
conduct assessments to identify the barriers or capacity needs that are hindering both 
caregivers and healthcare workers from ensuring that young adolescents are fully 
disclosed in line with the disclosure guidelines.  
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5.3.3 Capacity building and training  
With support from development partners, stakeholders and non-governmental 
organisations, the South African Department of Health must facilitate the implementation 
of on-going capacity building strategies for the relevant healthcare workers. The training 
of healthcare workers must aim to refresh skills, sensitise them to the existing disclosure 
guidelines and any updates thereof, as well as capacitate them to work together with 
caregivers to ensure that children enrolled on ART are appropriately disclosed.  
 
5.4 Further studies 
 
This study focused on determining the prevalence of HIV status disclosure among young 
adolescents enrolled on ART at the public healthcare facilities in the City of 
Johannesburg, Region A. The findings of the study suggest that there is a low prevalence 
of status disclosure. Further qualitative research is recommended to: 
  
 Investigate the barriers that are hindering healthcare workers and caregivers from 
ensuring that young adolescents enrolled on ART are fully disclosed in line with 
the South African National Disclosure Guidelines for Children and Adolescents in 
the context of HIV, TB and Non-Communicable Diseases. 
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